Red blood cells mediated delivery of 9-(2-phosphonylmethoxyethyl)adenine to primary macrophages: Efficiency, metabolism and activity against human immunodeficiency virus or herpes simplex virus

Antiviral Research

Volumn 33, Issue 3, 1997, Pages 153-164

  Perno, Carlo Federico ^a   Santoro, Nadia ^b   Balestra, Emanuela ^a   Aquaro, Stefano ^a   Cenci, Alessandra ^a   Lazzarino, Giuseppe ^c   Pierro, Donato Di ^a   Tavazzi, Barbara ^a   Balzarini, Jan ^d   Garaci, Enrico ^a   Grimaldi, Settimio ^b   Caliò, Raffaele ^a  

^a UNIVERSITY OF ROME TOR VERGATA   (Italy)

^b CNR   (Italy)

^c UNIVERSITY OF CATANIA   (Italy)

^d REGA INSTITUTE FOR MEDICAL RESEARCH   (Belgium)

Author keywords

Erythrocytes; Herpes simplex virus type 1; Human immunodeficiency virus; Macrophages; PMEA

Indexed keywords

ADEFOVIR; DRUG CARRIER;

ANIMAL CELL; ANTIVIRAL ACTIVITY; ARTICLE; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; DRUG METABOLISM; ERYTHROCYTE; HERPES SIMPLEX VIRUS 1; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS; MACROPHAGE; NONHUMAN; PRIORITY JOURNAL;

ADENINE; ANIMALS; ANTI-HIV AGENTS; ANTIVIRAL AGENTS; CELLS, CULTURED; CERCOPITHECUS AETHIOPS; DRUG CARRIERS; ERYTHROCYTES; HERPESVIRUS 1, HUMAN; HIV-1; HUMANS; MACROPHAGES; PHOSPHONIC ACIDS; VERO CELLS;

EID: 0031035735     PISSN: 01663542     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0166-3542(96)01011-X     Document Type: Article

References (44)

1. Balzarini, J. and De Clercq, E. (1991) 5-Phosphoribosyl-1-pyrophosphate synthetase converts the acyclic nucleoside phosphonates 9-(3-hydroxy-2-phosphonylmethoxypropyl) adenine and 9-(2-phosphonylmethoxyethyl)adenine directly to their antivirally active diphosphate derivatives. J. Biol. Chem. 266, 8686-8689.
2. Balzarini, J., Naesens, L., Herdewijn, P., Rosenberg, I., Holy, A., Pauwels, R., Baba, M., Johns, D.G. and De Clercq, E. (1989) Marked in vivo antiretrovirus activity of 9-(2-phosphonylmethoxyethyl)adenine, a selective anti-human immunodeficiency virus agent. Proc. Natl. Acad. Sci. USA 86, 332-336.
3. Balzarini, J., Perno, C.F., Schols, D. and De Clercq, E. (1991a) Activity of acyclic nucleoside phosphonates analogues against human immunodeficiency virus in monocyte/macrophages and peripheral blood lymphocytes. Biochem. Biophys. Res. Commun. 178, 329-335.
4. Balzarini, J., Hao, Z., Herdewijn, P., Johns, D.G. and De Clercq, E. (1991b) Intracellular metabolism and mechanism of anti-retrovirus action of 9-(2-phosphonylmethoxyethyl)adenine, a potent anti-human immunodeficiency virus compound. Proc. Natl. Acad. Sci. USA 88, 1499-1503.
5. Barditch-Crovo, P.A., Toole, J., Burgee, H., Wachsman, M., Ebeling, D., Cundy, K.C. and Jaffe H.S. (1995) A randomized, double-blind, placebo-controlled phase I/II evaluation of 9-[2-(bispivaloyloxy-methyl)phosphonyl-methoxy]adenine (Bis-POM PMEA), an orally bioavailable prodrug of the anti-HIV nucleotide, PMEA. Antiviral Res. 26, A229.
6. Borghi, P., Fantuzzi, L., Varano, B., Gessani, S., Puddu, P., Conti, L., Capobianchi, M.R., Ameglio, F. and Belardelli, F. (1995) Induction of interleukin-10 by human immunodeficiency virus type 1 and its gp120 protein in human monocytes/macrophages. J. Virol. 69, 1284-1287.
7. Calio', R., Villani, N., Balestra, E., Sesa, F., Holy, A., Balzarini, J., De Clercq, E., Perno, C.F. and Del Gobbo, V. (1994) Enhancement of natural killer activity and interferon induction by different acyclic nucleoside phosphonates. Antiviral Res. 23, 77-89.
8. Clague, M.J. and Cherry, R.J. (1989) A comparative study of band 3 aggregation in erythrocyte membranes by melittin and other cationic agents. Biochim. Biophys. Acta 980, 93-99.
9. De Clercq, E., Holy, A., Rosenberg, I., Sakuma, T., Balzarini, J. and Maudgal, P.C. (1986) A novel selective broad-spectrum anti-DNA virus agent. Nature 323, 464-467.
10. De Flora, A., Tonetti, M., Zocchi, E., Guida, L., Polvani, C., Gasparini, A. and Benatti, U. (1993) Engineered erythrocytes as carriers and bioreactors. Year Immunol. 7, 168-174.
11. Del Gobbo, V., Foli, A., Balestra, E., Villani, N., Marini, S., Perno, C.F. and Caliò, R. (1991) Immunomodulatory activity of phosphonyl-methoxy-ethyl-adenine (PMEA), a potent anti-HIV nucleoside analogue, on in vivo murine models. Antiviral Res. 16, 65-75.
12. Dudley, M.N. (1995) Clinical pharmacokinetics of nucleoside antiretroviral agents. J. Infect. Dis. 171, S99-S112.
13. Embretson, J., Zupancic, M., Ribas, J.L., Burke, A., Racz, P., Tenner Racz, K. and Haase, A.T. (1993) Massive covert infection of helper T lymphocytes and macrophages by HIV during the incubation period of AIDS. Nature 362, 359-362.
14. Fink, C.G., Read, S.J., Hopkin, J., Peto, T., Gould, S. and Kurtz, J.B. (1993) Acute herpes hepatitis in pregnancy. J. Clin. Pathol. 46, 968-971.
15. Garrett, C. and Santi, D.V. (1979) A rapid and sensitive high pressure liquid chromatography assay for deoxyribonucleoside triphosphates in cell extracts. Anal. Biochem. 99, 268-273.
16. Gendelman, H.E. and Meltzer, M.S. (1990) Mononuclear phagocytes and the human immunodeficiency virus. Curr. Opin. Immunol. 2, 414-419.
17. Giacomello, A. and Salerno, C. (1991) Possible metabolic basis for GTP depletion in red cells of patients with PRPP synthetase superactivity. Adv. Exp. Med. Biol. 309B, 253-256.
18. Golden, M.P., Kim, S., Hammer, S.M., Ladd, E.A., Schaffer, P.A., De Luca, N. and Albrecht, M.A. (1992) Activation of human immunodeficiency virus by herpes simplex virus. J. Infect. Dis. 166, 494-499.
19. Hartman, N.R., Yarchoan, R., Pluda, J.M., Thomas, R.V., Marczyk, K.S., Broder, S. and Johns, D.G. (1990) Pharmacokinetics of 2′,3′-dideoxyadenosine and 2′,3′-dideoxyinosine in patients with severe human immunodeficiency virus infection. Clin. Pharmacol. Ther. 47, 647-654.
20. Heng, M.C., Heng, S.Y. and Allen, S.G. (1994) Co-infection and synergy of human immunodeficiency virus-1 and herpes simplex virus-1. Lancet 343, 255-258.
21. Ho, D.D., Neumann, A.U., Perelson, A.S., Chen, W., Leonard, J.M. and Markowitz, M. (1995) Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection. Nature 373, 123-126.
22. Hui, S.W., Stewart, C.M. and Cherry, R.J. (1990) Electron microscopic conservation of the aggregation of membrane proteins in human erythrocytes by melittin. Biochim. Biophys. Acta 1023, 335-340.
23. Jennings, M.L. (1984) Oligomeric structure and anion transport function of human erythrocyte band 3 protein. J. Membrane Biol. 80, 105-117.
24. Lazzarino, G., Di Pierro, D., Tavazzi, B., Cerroni, L. and Giardina, B. (1991) Simultaneous separation of malondialdehyde, ascorbic acid and adenine nucleotide derivatives from biological samples by ion-pairing high-performance liquid chromatography. Anal. Biochem. 197, 191-196.
25. Lelkes, G., Fodor, I., Lelkes, G. and Hollman, S. (1986) The mobility of intramembrane particles in non-haemolysed human erytrocytes. Factors affecting acridine-orange-induced particle aggregation. J. Cell. Sci. 86, 57-67.
26. Lipton, S.A. and Gendelman, H.E. (1995) Dementia associated with the acquired immunodeficiency syndrome. N. Engl. J. Med. 332, 934-940.
27. Low, P.S. (1989) In: P. Agre and J.C. Parker (Eds.), Red Blood Cell Membranes, pp. 237-260. Marcel Dekker, New York.
28. Lutz, H.U., Bussolino, F., Flepp, R., Fasler, S., Stammler, P., Kazatchkine, M.D. and Arese, P. (1987) Naturally occurring anti-band 3 antibodies and complement together mediate phagocytosis of oxidatively stressed human erythrocytes. Proc. Natl. Acad. Sci. USA 84, 7368-7372.
29. Magnani, M., Bianchi, M., Rossi, L. and Stocchi, V. (1989) Human red blood cells as bioreactors for the release of 2′,3′-dideoxycytidine, an inhibitor of HIV infectivity. Biochem. Biophys. Res. Commun. 164, 446-542.
30. Magnani, M., Rossi, L., Brandi, G., Schiavano, G.F., Montroni, M. and Piedimonte, G. (1992) Targeting antiretroviral nucleoside analogues in phosphorylated form to macrophages: in vitro and in vivo studies. Proc. Natl. Acad. Sci. USA 89, 6477-6481.
31. Magnani, M., Rossi, L., Fraternale, A.., Silvotti, L., Quintavalla, F., Piedimonte, G., Matteucci, D., Baldinotti, F. and Bendinelli, M. (1994) Feline immunodeficiency virus infection of macrophages: in vitro and in vivo inhibition by dideoxycytidine-5′-triphosphate-loaded erythrocytes. AIDS Res. Hum. Retrovir. 10, 1179-1186.
32. Manouilov, K.K., White, C.A., Boudinot, F.D., Fedorov, I.I. and Chu, C.K. (1995) Lymphatic distribution of 3′-azido-3′-deoxythymidine and 3′-azido-2′,3′-dideoxyuridine in mice. Drug Metab. Disp. 23, 655-658.
33. Pantaleo, G., Graziosi, C., Demarest, J.F., Butini, L., Montroni, M., Fox, C.H., Orenstein, J.M., Kotler, D.P. and Fauci, A.S. (1993) HIV infection is active and progressive in lymphoid tissue during the clinically latent stage of disease. Nature 362, 355-358.
34. Perno, C.F. and Yarchoan, R. (1993) Culture of HIV in monocytes and macrophages. In: J.E. Coligan, A.M. Kruisbeek, D.H. Margulies, E.M. Shevach and W. Strober (Eds.), Current Protocols in Immunology, pp. 12.4.1-12.4.11. Wiley, New York.
35. Perno, C.F., Balestra, E., Aquaro, S., Panti, S., Cenci, A., Lazzarino, G., Tavazzi, B., Di Pierro, D., Balzarini, J. and Caliò, R. (1996) The potent inhibition of human immunodeficiency virus and herpes simplex virus type 1 by 9-(2-phosphonylmethoxyethyl)adenine (PMEA) in primary macrophages is determined by drug metabolism, nucleotide pools and cytokines. Mol. Pharmacol. 50, 394-401.
36. Piedimonte, G., Montroni, M., Silvestri, G., Silvotti, L., Donatini, A., Rossi, L., Borghetti, A.F. and Magnani, M. (1993) Phagocytosis reduces HIV-1 production in human monocytes/macrophages infected in vitro. Arch. Virol. 130, 463-469.
37. Robbins, B.I., Greenhaw, J., Connelly, M.C. and Fridland, A. (1995) Metabolic pathways for activation of the antiviral agent 9-(2-phosphonylmethoxyethyl)adenine in human lymphoid cells. Antimicrob. Agents Chemother. 39, 2304-2308.
38. Rossi, L., Brandi, G., Fraternale, A., Schivano, G.F., Chiarantini, L. and Magnani, M. (1993) Inhibition of murine retrovirus-induced immunodeficiency disease by dideoxycytidine and dideoxycytidine 5'-triphosphate. J. Acquir. Immun. Defic. Syndr. Hum. Retrovirol. 6, 1179-1186.
39. Sakuma, R., Nishina, T., Yamanaka, H., Kamatani, N., Nishioka, K., Maeda, M. and Tsuji, A. (1991) Phosphoribosylpyrophosphate synthetase in human erythrocytes: assay and kinetic studies using high-performance liquid chromatography. Clin. Chim. Acta 203, 143-152.
40. Silverstein, S.C., Greenberg, S., Di Virgilio, F. and Steinberg, T.H. (1989) Phagocytosis. In: W.E. Paul (Ed.), Fundamental Immunology, pp. 703-719. Raven Press, New York.
41. Turrini, F., Arese, P., Yuan, J. and Low, P.S. (1991) Clustering of integral membrane proteins of the human erythrocyte membrane stimulates autologous IgG binding, complement deposition, and phagocytosis. J. Biol. Chem. 226, 23611-23617.
42. Wei, X., Ghosh, S.K., Taylor, M.E., Johnson, V.A., Emini, E.A., Deutsch, P., Lifson, J.D., Bonhoeffer, S., Nowak, M.A. and Hahn, B.H. (1995) Viral dynamics in human immunodeficiency virus type 1 infection. Nature 373, 117-122.
43. Wieth, J.O. and Brahm, J. (1985) Cellular anion transport. In: D.W. Seldin and G. Giebisch (Eds.), The Kidney: Physiology and Pathophysiology, pp. 49-90. Raven Press, New York.
44. Yarchoan, R., Perno, C.F., Thomas, R.V., Klecker, R.W., Allain, J.P., Wills, R.J., McAtee, N., Fischl, M.A., Dubinsky, R., McNeely, M.C., Mitsuya, H., Pluda, J.M., Lawley, T.J., Leuther, M., Safai, B., Collins, J.M., Myers, C.E. and Broder, S. (1988) Phase I studies of 2′,3′-dideoxycytidine in severe human immunodeficiency virus infection as a single agent and alternating with zidovudine (AZT). Lancet i, 76-81.